15.09.2014 • News

Bayer Completes Sale of Interventional Device Business

Bayer HealthCare has completed the sale of its interventional device business to Boston Scientific for $ 415 million.

The German company said the divestment will allow its medical care division to concentrate on innovation and growth in radiology and diabetes care, where it already has a strong presence.

The transaction includes the AngioJet (thrombectomy) and Jetstream (atherectomy) systems, and the FetchAspiration catheter used in cardiology, radiology and peripheral vascular procedures.

Bayer's Interventional business had sales of $120 million in 2013.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.